Chris Thome
Analyst · Noble Capital Markets
Thank you, Matt, and good morning, everyone. As a reminder, our results include P3 Technologies for the full quarter. We acquired P3 in November of 2023 and this impacts the year-over-year comparisons. I will begin on Slide 5. As you can see, we had another record quarter achieving sales of $50 million. This represents a 5% increase or $2.4 million over the prior year and includes $1.6 million of incremental sales from P3. Sales to the defense market reached $29.1 million marking a 28% increase and setting a new quarterly record. Another contributor to our overall sales growth was a 20% rise in refining sales, which totaled $8.2 million. The decline in our other revenue was due to the timing of projects with multiple customers across various markets. It is worth noting that while aftermarket sales were down compared with the record levels of the prior year, they remain robust overall. This demonstrates the ongoing strength of our aftermarket business. U.S. Sales accounted for 82% of our total revenue this quarter, which reflects the size and scope of our domestic defense business. On Slide 6, you could see that our gross margin reached 24.8% for the quarter, an expansion of 170 basis points over the prior year. I should point out that this quarter's gross margin benefited $480,000 from the BlueForge Alliance Grant that Dan discussed earlier, which is a strategic investment in our workforce development ensuring we have the skilled labor necessary for future growth. Additionally, P3 continued to provide margin accretive sales reinforcing the value of this acquisition and we benefited from improved execution and pricing on our defense contracts. It is also worth noting that we are beginning to see improved profitability in our recent refinery projects in India, a promising development driven by new leadership and localized engineering efforts that enhance our efficiency and cost effectiveness. On Slide 7, you can see how our strong performance is translating into our improving bottom line. We continue to trend upward both quarter-by-quarter and year-over-year. Net income for the first quarter was $3 million a 12% increase compared with $2.6 million for the same period in 2024. This translates to $0.27 per share. Adjusted net income saw an even higher increase up 20% to $3.6 million equating to $0.33 per share. Our lower tax rate for the quarter reflected a discrete tax benefit related to the vesting of restricted stock awards. For the full year, we still expect an effective tax rate of 20% to 22%. Slide 8 shows our adjusted EBITDA, which was $5.1 million for the first quarter and represented a 10.3% margin. Expenses were higher this quarter with SG&A inclusive of amortization increasing by $2 million year-over-year. This rise was largely due to our continued investment in our operations, our people and our technologies. This included a $0.3 million increase in the supplemental performance bonus from the Barber-Nichols acquisition, a $0.3 million of incremental costs of incremental costs associated with the P3 acquisition, $0.3 million of expenses for the ERP conversion at Batavia and $0.4 million of increased investment in R&D. I should point out that SG&A expenses were down versus the sequential fourth quarter due to lower performance based compensation and professional services fees. Turning to Slide 9, we had another quarter of strong cash generation totaling $8.7 million. Our balance sheet remains very strong with $21.6 million in cash and no debt. The $29 million of availability on our senior revolving credit facility at June 30 provides additional financial flexibility to support our strategic initiatives and operational needs. Capital expenditures for the quarter were $3 million directed towards capacity expansion and productivity improvements such as automated welding equipment and new machining centers. For fiscal 20 25, we still expect CapEx to be between $10 million to $15 million. Approximately half of this amount is related to the customer supported expansion of our Batavia facility, which will accommodate an accelerated shipbuilding schedule for the U.S. Navy. Turning to Slide 10, you'll see that we achieved orders of $55.8 million in the quarter resulting in a book-to-bill ratio of 1.1x. Approximately half of these orders were for the defense sector including the award for the Mark 48 program that Matt discussed. Another significant driver was the 53% increase in chemical and petrochemical orders, which included the order for the ethylene cracker that Dan mentioned. Slide 11 shows that our backlog has been consistently around the $400 million level for the past three quarters, further underscoring our consistent demand and strong market position. This stable backlog provides us with good visibility into the future and ensures a level of operational stability. Overall, our backlog increased 23% year-over-year with defense backlog up 29% or $74.5 million and our chemical petrochemical backlog up 82% or $10.5 million. Approximately 35% to 45% of our backlog is expected to convert to sales within the next 12-months with an additional 25% to 30% expected to convert over the following 12-months. The majority of orders expected to convert beyond 12-months are from the defense industry, specifically for the U.S. Navy. On Slide 12, you can see that we are reiterating our guidance for fiscal 2025 that we provided last quarter. We continue to expect revenue to be between $200 million and $210 million indicating top line growth of 11% over fiscal 2024 at the midpoint of this range. We have accounted for the seasonal cadence in our projections with historically lighter second and third quarters due to holidays and direct labor vacations. From a margin perspective, we continue to expect our gross margin to range from 22% to 23% for the full year and our SG&A including amortization to be between 16.5% to 17.5% of sales. Our SG&A guidance includes costs associated with the Barber-Nichols supplemental bonus from the acquisition, equity based compensation and ERP conversion costs of approximately $6.5 million to $7.5 million. The net result is that we expect adjusted EBITDA for fiscal year 2025 to be between $16.5 million to $19.5 million which implies a 35% increase at the midpoint. The range also implies an adjusted EBITDA margin of about 9% at the midpoint or a nearly 200 basis point improvement over fiscal 2024. With that, I will pass the call back to Dan.